LYPLAL1 and type 2 diabetes mellitus: In our previous study, we identified lncRNA LYPLAL1-DT (LYPLAL1 divergent transcript) significantly enhances the proliferation and migration of endothelial cells under inflammatory and high glucose conditions to protect against type 2 diabetes with macrovascular complications[14].